Opendoor Technologies Inc.'s stock soared 470%, driven by hype, not fundamentals. Click for our take on OPEN stock and ...

These five stocks are likely to continue making shareholders wealthy. They dominate their core businesses across the consumer ...

Still a popular over-the-counter option in Russia today, the drug promises to curb anxiety, cure insomnia, manage alcohol ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

American depositary receipts of RedHill Biopharma climbed after the company said it received positive Food and Drug Administration feedback on its treatment for Crohn's disease. The ADRs were up 24%, ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Shares of Viking ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...

Laura, in her early 40s, describes a similar heartbreak when her boyfriend of a year started consuming red-pill content during the pandemic, which eventually caused them to break up.

Object Details Location Currently not on view Credit Line Gift of Richard W. Pollay ID Number 2008.0018.067 catalog number 2008.0018.067 accession number 2008.0018 Object Name otc preparation Object ...

The latest biotech stock to explode in price, Nektar Therapeutics (NASDAQ: NKTR) was quite the outperformer on the stock exchange for the second day in a row. On Wednesday, one day after ...